Oncology
The Mechanisms of Resistance: A Deeper Dive into Multimodal Escape in Multiple Myeloma
The newest class of myeloma immunotherapies target a surface protein called GPRC5D.
Rayan Salih · March 16, 2026 · 10 min
Living with Multiple Myeloma
Stories from people navigating Multiple Myeloma — diagnosis, treatment, caregiving, and the ordinary days in between.
2 stories
Oncology
Teclistamab–Daratumumab Approved for Relapsed/Refractory Myeloma
The US Food and Drug Administration (FDA) has approved a new combination treatment for patients with relapsed/refractory multiple
Rayan Salih · 9 min read
Other conditions
One story a day
The story of the day, in your inbox
One health journey each morning — no advice, no alarm, just company for the road.